Quick Summary

Yerba Santa (Eriodictyon californicum) is a plant traditionally used in herbal medicine. Current research on Yerba Santa specifically is limited, with no direct clinical trials or systematic reviews available. Some related flavanone compounds derived from this plant, such as eriodictyol, have been investigated mainly in preclinical models, indicating potential biological activities relevant to cancer and inflammation. However, clinical evidence for its therapeutic use, safety, and adverse effects in humans is not established.

What Is It?

Yerba Santa is a plant native to the southwestern United States, recognized for its aromatic leaves and traditional medicinal applications. Its botanical name is Eriodictyon californicum. The plant contains several bioactive flavonoids, including eriodictyol, which have been studied in laboratory settings.

Traditional Uses

Traditionally, Yerba Santa has been used by indigenous peoples and herbalists for respiratory conditions and other general health purposes. Despite its historical use, there is limited scientific validation regarding these applications.

Active Compounds

  • Eriodictyol – a flavanone compound with noted biological activity in preclinical studies
  • Related flavonoids such as quercetin, which may contribute to antioxidant and anti-inflammatory effects

Potential Benefits with Evidence Levels

  • Potential anti-cancer properties (Preclinical evidence): Compounds like eriodictyol isolated from Yerba Santa have shown modulation of cancer cell cycle, apoptosis, and oncogenic signaling in cell and animal studies. However, no robust clinical trials confirm efficacy in humans.
  • Antioxidant and anti-inflammatory effects (Preclinical and mechanistic evidence): Flavonoids related to those found in Yerba Santa suggest antioxidant and anti-inflammatory effects, though direct clinical evidence for Yerba Santa is lacking.
  • Appetite suppression and satiety effects (Insufficient clinical evidence): Although some phytochemicals have been assessed for appetite suppression, evidence specific to Yerba Santa is inconclusive.

Side Effects

No clinical data on adverse effects related to Yerba Santa are currently available. Existing research does not report or analyze adverse effects in humans.

Drug Interactions

There is no evidence or reported clinical data on drug interactions involving Yerba Santa or its bioactive compounds.

Who Should Avoid It

Due to insufficient clinical research, no specific contraindications have been established. Additionally, safety during pregnancy and breastfeeding is unknown, so caution is advised, and consultation with a healthcare professional is recommended before use in these populations.

Evidence Limitations

  • No clinical trials or systematic reviews focusing directly on Yerba Santa have been identified.
  • Existing evidence is largely preclinical, based on isolated compounds such as eriodictyol, with limited translational or clinical validation.
  • Lack of safety, pharmacokinetics, dosage, and interaction studies in humans.
  • Inconsistent or inconclusive evidence on efficacy for appetite suppression and other potential uses.
  • There is a need for rigorous, well-designed clinical studies to establish therapeutic benefits and safety.

References

Last Reviewed

April 2024

Disclaimer: This information is provided for educational purposes only and is not intended as medical advice. Yerba Santa has not been thoroughly studied in humans, and its safety and efficacy remain uncertain. Always consult a qualified healthcare provider before using herbal products, especially if you are pregnant, breastfeeding, have existing health conditions, or are taking medications.